Top

Reactions Weekly

Published in:

01-06-2020 | Bevacizumab | Case report

Oxaliplatin/capecitabine/bevacizumab

Oesophageal varices rupture: case report

Published in: Reactions Weekly | Issue 1/2020

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Lee T, et al. [A Case of Rupture of Esophageal Varices during a Course of CAPOX with Bevacizumab Therapy for Sigmoid Colon Cancer with Multiple Liver Metastases]. Gan to Kagaku Ryoho 46: 2360-2362, No. 13, Dec 2019. Available from: URL: https://pubmed.ncbi.nlm.nih.gov/32156931/ [Japanese; summarised from a translation]

Title: Oxaliplatin/capecitabine/bevacizumab
Oesophageal varices rupture: case report
Publication date: 01-06-2020
Publisher: Springer International Publishing
Keywords: Bevacizumab
Colon Cancer
Colon Cancer
Published in: Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-79437-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Oxaliplatin/capecitabine/bevacizumab

Oesophageal varices rupture: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Lenvatinib

Budesonide/formoterol

Buprenorphine/fentanyl

Ciprofloxacin/rasagiline interaction

Cyclophosphamide/etoposide/tocilizumab

Azathioprine